Of note, the mutations we tracked (NPM1 or IDH2) were still present at relapse because, as previously shown, NPM1-negative relapse in AML is quite rare when NPM1 is present at initial diagnosis.44 This evidence concerns the gene NPM1 and acute myeloid leukemia.